부탄이산 시장 : 세계 예측(2026-2032년)

The Butanedioic Acid Market is projected to grow by USD 551.26 million at a CAGR of 7.49% by 2032.

Butanedioic Acid: Executive Summary and Strategic Context

Butanedioic acid, also known as succinic acid, is a four-carbon dicarboxylic acid used in chemical intermediates, pharmaceuticals, food and beverage applications, polymers, coatings, and other formulation processes. Its strategic relevance reflects the breadth of downstream uses, the availability of petroleum-based and bio-based production routes, and growing attention to process efficiency, feedstock resilience, and environmental performance. Market conditions vary according to industrial activity, regulatory requirements, end-use formulation standards, and access to reliable raw materials.

Production Flexibility and Sustainability Are Reshaping the Landscape

The industry is evolving through the coexistence of conventional petrochemical pathways and fermentation-based production. Bio-based routes can support lower-fossil-carbon positioning when supported by suitable feedstocks, process yields, purification systems, and credible lifecycle evidence. At the same time, producers and users continue to prioritize consistent specification, impurity control, supply continuity, and cost discipline. Regulatory scrutiny of chemicals, solvents, emissions, waste, and product claims is encouraging investments in cleaner processing, traceability, and more efficient resource use.

Artificial Intelligence Strengthens Planning, Quality, and Process Control

Artificial intelligence can influence the butanedioic acid value chain by improving demand sensing, production scheduling, predictive maintenance, anomaly detection, laboratory analytics, and formulation support. Machine-learning models can help identify relationships among feedstock quality, fermentation or reaction conditions, purification performance, and final-product specifications. Digital tools also support inventory optimization and documentation. However, benefits depend on reliable historical data, validated models, cybersecurity, operator expertise, and governance suitable for regulated chemical and pharmaceutical applications. AI should therefore augment technical judgment rather than replace process validation or quality oversight.

Regional Insights: Diverse Industrial Bases Require Localized Strategies

North America combines established chemical, pharmaceutical, food, and advanced-materials capabilities with strong interest in supply resilience and lower-carbon manufacturing. Latin America presents opportunities linked to agricultural resources, food processing, and industrial development, while infrastructure and logistics conditions vary by country. Europe places particular emphasis on chemical safety, circularity, emissions reduction, and traceable sustainability claims. The Middle East benefits from integrated industrial infrastructure and feedstock access, with diversification agendas supporting downstream chemicals. Africa's development is shaped by uneven manufacturing capacity, import dependence in some markets, and emerging opportunities in food, pharmaceuticals, and industrial processing. Asia-Pacific remains highly diverse, combining major chemical and manufacturing centers with expanding pharmaceutical, food, packaging, and materials applications.

Group Insights: Trade, Regulation, and Industrial Coordination Matter

ASEAN economies offer a varied manufacturing base and important regional supply-chain links, but regulatory implementation and infrastructure differ across members. BRICS countries span major feedstock, manufacturing, pharmaceutical, agricultural, and consumer markets, creating both collaboration potential and complex trade dynamics. The European Union operates under closely coordinated chemical, environmental, and product-safety frameworks. G7 economies generally combine advanced research, demanding quality systems, and mature downstream industries. GCC members are supported by integrated energy and chemicals ecosystems while pursuing broader industrial diversification. NATO members are not a single commercial bloc, yet shared attention to industrial resilience, critical supply chains, and advanced manufacturing can influence procurement and investment priorities.

Country Insights: Application Mix and Policy Conditions Differ Widely

Australia's resource base and regional trade links support opportunities in specialty chemicals and processing. Brazil combines agricultural capability with substantial food, pharmaceutical, and industrial demand. Canada offers advanced manufacturing, life-science, and resource-sector linkages. China has extensive chemical and downstream manufacturing capacity across polymers, pharmaceuticals, and consumer products. France, Germany, Italy, and Spain combine sophisticated European industrial and formulation sectors with stringent environmental and quality requirements. India's pharmaceutical, food, and manufacturing industries create broad application diversity. Japan and South Korea emphasize high-specification manufacturing, electronics-related materials, and process quality. Mexico benefits from industrial integration with North American supply chains. Russia's industrial and chemical base is affected by trade, financing, and supply-chain constraints. The United Kingdom maintains strengths in pharmaceuticals, specialty chemicals, research, and regulated applications. The United States combines deep chemical, healthcare, food, and advanced-materials ecosystems with strong innovation and compliance capabilities.

Action Priorities for Leaders in Butanedioic Acid Value Chains

Industry leaders should segment customers by specification, regulatory sensitivity, and sustainability requirements rather than treating butanedioic acid as a uniform product. They should qualify multiple feedstock and logistics options, strengthen supplier audits, and maintain contingency plans for critical inputs and purification materials. Investments in fermentation efficiency, energy management, solvent recovery, waste reduction, and analytical automation should be assessed against validated lifecycle and quality outcomes. Companies should build application partnerships with pharmaceutical, food, polymer, and specialty-chemical users; establish disciplined data governance before scaling AI; and document environmental claims with transparent, auditable evidence. Regional operating models should reflect local regulations, infrastructure, tariffs, and customer qualification cycles.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the supplied market scope for butanedioic acid and organizes the analysis around production pathways, downstream applications, technology adoption, sustainability, regulation, supply-chain resilience, and geographic context. Insights are derived from established industry relationships and publicly verifiable categories of evidence, including regulatory frameworks, technical literature, company disclosures, trade and industrial data, and documented manufacturing practices. No market estimates, market sizes, market shares, forecasts, or unsupported company-specific claims are used. Regional, group, and country observations are presented as qualitative interpretations and should be validated against current local regulations, operating data, and application-specific qualification requirements.

Conclusion: Resilience and Verified Sustainability Will Define Competitiveness

Butanedioic acid remains strategically important because it connects diverse chemical, pharmaceutical, food, polymer, and materials value chains. Competitive advantage will increasingly depend on dependable quality, flexible sourcing, efficient production, credible sustainability performance, and close alignment with downstream customer requirements. Producers and users that combine process discipline with selective digitalization, transparent environmental evidence, and geographically resilient supply planning will be better positioned to manage regulatory and operational complexity. The strongest strategies will remain application-led, data-governed, and tailored to the distinct conditions of each region and country.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Butanedioic Acid Market, by Type

• 7.1. Introduction
• 7.2. Flaky
• 7.3. Granular
• 7.4. Powder

8. Butanedioic Acid Market, by Manufacturing Process

• 8.1. Introduction
• 8.2. Bio Based
  • 8.2.1. Enzymatic
  • 8.2.2. Fermentation
• 8.3. Petrochemical

9. Butanedioic Acid Market, by Purity Grade

• 9.1. Introduction
• 9.2. Food Grade
• 9.3. Industrial Grade
• 9.4. Pharmaceutical Grade

10. Butanedioic Acid Market, by Application

• 10.1. Introduction
• 10.2. Agriculture
  • 10.2.1. Plant Growth Regulator
  • 10.2.2. Soil Amendment
• 10.3. Chemical Intermediates
  • 10.3.1. Polymeric Precursors
  • 10.3.2. Resins
  • 10.3.3. Surfactants
• 10.4. Food & Beverage
  • 10.4.1. Acidulant
  • 10.4.2. Flavor Enhancer
  • 10.4.3. Nutraceuticals
• 10.5. Pharmaceutical
  • 10.5.1. Injectables
  • 10.5.2. Oral Formulations
  • 10.5.3. Topicals

11. Butanedioic Acid Market, by End User Industry

• 11.1. Introduction
• 11.2. Automotive
• 11.3. Construction
• 11.4. Packaging
• 11.5. Textiles

12. Butanedioic Acid Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Butanedioic Acid Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Butanedioic Acid Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Anhui BBCA Biochemical Technology Co., Ltd.
• 16.2. Anhui Sunsing Chemicals Co Ltd
• 16.3. Baoji Jinbaoyu Technology Co Ltd
• 16.4. BASF SE
• 16.5. Corbion N.V.
• 16.6. Feiyang Chemical Co Ltd
• 16.7. GC Innovation America Inc
• 16.8. Jiangsu Qianchen Biotech Co., Ltd.
• 16.9. Kawasaki Kasei Chemicals Ltd
• 16.10. Koninklijke DSM N.V.
• 16.11. Mitsubishi Chemical Holdings Corporation
• 16.12. Myriant Corporation
• 16.13. Novamont S.p.A.
• 16.14. Roquette Freres
• 16.15. Shandong Landian Biological Technology Co Ltd
• 16.16. Shanghai Shenren Fine Chemical Co Ltd
• 16.17. Tianjin Harmony Technology Development Co Ltd
• 16.18. Weinan Huifeng New Material Technology Co Ltd
• 16.19. Yantai Bingde Biochemical Co., Ltd.

17. Key Experts